Zhejiang, Is A Prominent Player In The Pharmaceutical Industry. As A Publicly Traded Subsidiary Of The Hengdian Group, It Employs Over 7,000 People And Ranks As One Of China'S Top Exporters Of Active Pharmaceutical Ingredients (Apis) And A Leading Contract Development And Manufacturing Organization (Cdmo). The Company Operates Multiple Manufacturing Sites Across Zhejiang, Shandong, And Anhui.Apeloa Specializes In The Production Of Generic Apis For Various Therapeutic Areas, Including Cardiovascular, Anti-Infection, Psychotropic, And Anti-Cancer Treatments. It Offers Comprehensive Cdmo Services, Supporting Global Pharmaceutical Companies With End-To-End Solutions From Preclinical Development To Commercial Manufacturing. Additionally, Apeloa Produces Finished Dosage Forms, Including Branded Formulations, And Is Expanding Into Cosmetic And Personal Care Ingredients. With A Strong Focus On Research And Development, The Company Has Over 600 Projects And Collaborates With Leading Academic Institutions To Drive Innovation And Maintain High Compliance With International Regulatory Standards.
